The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2017-08-29
DOI
10.1038/s41598-017-10386-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-1 says goodbye, TIM-3 says hello
- (2016) Diana Romero Nature Reviews Clinical Oncology
- Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis
- (2015) Binglan Zhang et al. ORAL ONCOLOGY
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
- (2014) A. C. Anderson Cancer Immunology Research
- Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge
- (2013) Tao Xu et al. Current Oncology
- Immunotherapy-induced CD8+ T Cells Instigate Immune Suppression in the Tumor
- (2013) A J Robert McGray et al. MOLECULAR THERAPY
- Nasopharyngeal carcinoma: Salvage of local recurrence
- (2012) Anne W.M. Lee et al. ORAL ONCOLOGY
- Host–tumor interactions in nasopharyngeal carcinomas
- (2012) Claire Gourzones et al. SEMINARS IN CANCER BIOLOGY
- Current Management of Nasopharyngeal Cancer
- (2012) Anne W.M. Lee et al. SEMINARS IN RADIATION ONCOLOGY
- Radiation-induced effects and the immune system in cancer
- (2012) Punit Kaur et al. Frontiers in Oncology
- Salvage Treatment for Isolated Regional Failure of Nasopharyngeal Carcinoma after Primary Radiotherapy
- (2011) Wu-Chia Lo et al. ANNALS OF SURGICAL ONCOLOGY
- Increase of programmed death-1-expressing intratumoral CD8 T cells predicts a poor prognosis for nasopharyngeal carcinoma
- (2010) Mei-Chi Hsu et al. MODERN PATHOLOGY
- Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced ζ-chain expression in nasopharyngeal carcinoma patients
- (2009) W. K. Yip et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells
- (2008) J. Klibi et al. BLOOD
- Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis
- (2008) Masako Seki et al. CLINICAL IMMUNOLOGY
- Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells
- (2008) Feng Wang et al. IMMUNOBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started